Lancashire and South Cumbria
Formulary
 
back
4 Central nervous system

This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net. 

For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/

04-07-03 Neuropathic pain

Duloxetine Cymbalta®
Second Choice
See section 4.3.4

Green View adult BNF  View SPC online  View childrens BNF
Gabapentin
Second Choice

See section 4.8.1
Link  MHRA: Gabapentin (Neurontin): risk of severe respiratory depression

Controlled Drug  Green View adult BNF  View SPC online  View childrens BNF
Ketamine oral solution
Restricted

Liquid 50mg/5mL

Unlicensed

For chronic pain - RED

Restricted Item For palliative care only AMBER - under review

Restricted Drug Controlled Drug  Red View adult BNF  View SPC online  View childrens BNF
Lidocaine
Formulary

5% Medicated Plasters

Post Herpetic Neuralgia

 

Green View adult BNF  View SPC online  View childrens BNF
Lidocaine
Formulary

5% Medicated Plasters

Use outside of the license of post-herpetic neuralgia for the treatment of localised neuropathic pain with predominance of allodynia and/or hyperalgesia and dysesthesias unresponsive to other neuropathic agents.

 

Red View adult BNF  View SPC online  View childrens BNF
Pregabalin
Formulary

See section 4.8.1
Link  MHRA: Pregabalin (Lyrica): findings of safety study on risks during pregnancy
Link  MHRA: Pregabalin (Lyrica): reports of severe respiratory depression

Controlled Drug  Green View adult BNF  View SPC online  View childrens BNF